BioCentury
ARTICLE | Regulation

FDA uses informal channel to disavow Makary’s informal policy pronouncements

Acting commissioner’s unreleased letter to Rep. DeGette leaves drug companies, investors and patients in a quandary

July 17, 2026 9:38 PM UTC

Acting FDA Commissioner Kyle Diamantas has vowed to abandon his predecessor’s policy-by-podcast approach and return to conventional methods for communicating agency guidance.

Ironically, Diamantas chose a non-public channel, a private letter to a member of Congress, to affirm FDA's commitment to following its own rules on communicating policy...